Tesamorelin is preferable for those interested in cognitive benefits along with metabolic improvements, whereas CJC-1295 offers a more general benefit to overall wellness and metabolism
Mitochondrial dysfunction and oxidative stress in heart disease
GHRH Peptides Side-by-Side Feature Receptor Target Tesamorelin GHRH receptor Sermorelin GHRH receptor CJC-1295 (DAC) GHRH receptor Feature Peptide Length Tesamorelin 44 amino acids (modified) Sermorelin 29 amino acids CJC-1295 (DAC) 29 amino acids + DAC Feature Half-Life Tesamorelin 26-38 minutes Sermorelin 11-12 minutes CJC-1295 (DAC) ~6-8 days Feature Dosing Frequency Tesamorelin Once daily Sermorelin Once nightly CJC-1295 (DAC) 1-2x weekly Feature FDA Status Tesamorelin Approved (2010
Tesamorelin Reconstitution Vial Size, BAC Water, and Dose Volumes Vial Size 2 mg BAC Water 0.5 mL Concentration 4,000 mcg/mL 1 mg Dose 0.25 mL (25 units) 1.4 mg Dose 0.35 mL (35 units) 2 mg Dose 0.50 mL (50 units, full vial) Vial Size 2 mg BAC Water 1.0 mL Concentration 2,000 mcg/mL 1 mg Dose 0.50 mL (50 units) 1.4 mg Dose 0.70 mL (70 units) 2 mg Dose 1.0 mL (100 units, full vial) Vial Size 5 mg BAC Water 1.0 mL Concentration 5,000 mcg/mL 1 mg Dose 0.20 mL (20 units) 1.4 mg Dose 0.28 mL (28 units) 2 mg Dose 0.40 mL (40 units) Vial Size 5 mg BAC Water 2.5 mL Concentration 2,000 mcg/mL 1 mg Dose 0.50 mL (50 units) 1.4 mg Dose 0.70 mL (70 units) 2 mg Dose 1.0 mL (100 units) Vial Size 10 mg BAC Water 2.0 mL Concentration 5,000 mcg/mL 1 mg Dose 0.20 mL (20 units) 1.4 mg Dose 0.28 mL (28 units) 2 mg Dose 0.40 mL (40 units) Vial Size 10 mg BAC Water 5.0 mL Concentration 2,000 mcg/mL 1 mg Dose 0.50 mL (50 units) 1.4 mg Dose 0.70 mL (70 units) 2 mg Dose 1.0 mL (100 units) U-100 insulin syringes have 100 units = 1.0 mL
